Western blot of ASCL1 (E158) pAb in extracts from Jurkat cells.
ASCL1 / MASH1 Antibody (Glu158)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human, Mouse, Rat |
| Format: | Liquid |
$328.00each
Catalog Number: LS-C177728-50
Catalog Number: LS-C177728
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- MASH1 antibody LS-C177728 is an unconjugated rabbit polyclonal antibody to MASH1 (ASCL1) (Glu158) from human. It is reactive with human, mouse and rat. Validated for IHC and WB. Cited in 1 publication.
- Application
- IHC, IHC-P, WB
- Reactivity
- Hu, Ms, Rt
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- Achaete-scute homolog 1 | ASH-1 | ASCL1 | BHLHa46 | Achaete scute protein | Achaete-scute complex-like 1 | HASH1 | MASH1 | ASH1
- Recommended Dilution: IHC-P
- 1:50 - 1:200
- Recommended Dilution: WB
- 1:500 - 1:1000
- UniProt Number
- P50553
- NCBI GenBank
- NM_004316 | NP_004307.2
- SwissProt
- P50553
Target
- Target
- Human ASCL1 / MASH1
- Antigen Species
- Human
- Epitope
- Human MASH1
- Gene Name
- ASCL1
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen
- Synthetic peptide around Glu158 of human MASH1
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.2, 0.02% Sodium Azide, 50% Glycerol
- Volume
- 50 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer. McColl K, Wildey G, Sakre N, Lipka MB, Behtaj M, Kresak A, Chen Y, Yang M, Velcheti V, Fu P, Dowlati A. Oncotarget. 2017 August;8:73745-73756. PubMed: 29088741 PMC: PMC5650296